Patent applications and USPTO patent grants for Impact Biomedicines, Inc..The latest application filed is for "bet inhibitors as a treatment for myelofibrosis".
Patent | Date |
---|---|
Bet Inhibitors As A Treatment For Myelofibrosis App 20220265617 - Aronchik; Ida ;   et al. | 2022-08-25 |
Methods of treating myeloproliferative disorders Grant 11,400,092 - Berry , et al. August 2, 2 | 2022-08-02 |
Methods Of Treating Myeloproliferative Disorders App 20220133724 - Berry; Tymara ;   et al. | 2022-05-05 |
Methods Of Treating Myeloproliferative Disorders App 20220133751 - Gerike; Torsten Guenter ;   et al. | 2022-05-05 |
Methods Of Treating Myeloproliferative Disorders App 20220031713 - Gerike; Torsten Guenter ;   et al. | 2022-02-03 |
Methods Of Treating Myeloproliferative Disorders App 20220031699 - Berry; Tymara ;   et al. | 2022-02-03 |
Compositions And Methods For Treating Myelofibrosis App 20210244735 - Jayan; Arvind ;   et al. | 2021-08-12 |
Compositions And Methods For Treating Myelofibrosis App 20190381041 - Jayan; Arvind ;   et al. | 2019-12-19 |
Compositions and methods for treating myelofibrosis Grant 10,391,094 - Jayan , et al. A | 2019-08-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.